Diagnostic Performance of Magnetic Resonance Imaging for Assessing Tumor Response in Patients With HER2-Negative Breast Cancer Receiving Neoadjuvant Chemotherapy is Associated With Molecular Biomarker Profile

Micro-Abstract The influence of hormone receptors (HRs) and the Ki-67 proliferation marker in the accuracy of measuring tumor size by magnetic resonance imaging (MRI) after chemotherapy was investigated in 54 patients with HER2-negative (HER2− ) breast cancer. The accuracy was higher in HR-negative...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Clinical breast cancer 2012-04, Vol.12 (2), p.110-118
Hauptverfasser:	Kuzucan, Aida, Chen, Jeon-Hor, Bahri, Shadfar, Mehta, Rita S, Carpenter, Philip M, Fwu, Peter T, Yu, Hon J, Hsiang, David J.B, Lane, Karen T, Butler, John A, Feig, Stephen A, Su, Min-Ying
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Aged Aged, 80 and over Antineoplastic Combined Chemotherapy Protocols - therapeutic use Biomarkers, Tumor - analysis Breast Neoplasms - diagnosis Breast Neoplasms - drug therapy Breast Neoplasms - metabolism Chemotherapy, Adjuvant Female Hematology, Oncology and Palliative Medicine Hormone receptors Humans Immunohistochemistry Ki-67 Magnetic Resonance Imaging Middle Aged Neoadjuvant chemotherapy Neoadjuvant Therapy Obstetrics and Gynecology Pathologic complete response Receptor, ErbB-2 - biosynthesis Receptors, Estrogen - biosynthesis Receptors, Progesterone - biosynthesis Sensitivity and Specificity Triple-negative cancer
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!